ACTRN12609000672257CompletedPhase 1
A Phase 1 Study of Epidermal Growth Factor Receptor (EGFR) Targeted, Paclitaxel Loaded EnGeneIC Delivery Vehicles in Patients with Advanced Solid Tumours
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- EnGeneIC Pty Ltd
- Enrollment
- 32
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Treatment
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Patients with advanced solid tumours that are metastatic or unresectable. Patients must have tumour types known to express EGFR.
Exclusion Criteria
- •Previous treatment with taxanes, treatment with EGFR inhibitor or other chemotherapy or radiotherapy in past 30 days, salmonella vaccination in past 12 months, hypersensitivity to monoclonal antibodies or taxanes, uncontrolled brain metastases
Investigators
Similar Trials
Withdrawn
Phase 2
The Effects of Epidermal Growth Factor Receptor (EGFR) Inhibition on Pulmonary Arterial Hypertension Associated with Systemic Sclerosis A phase II controlled open-label safety and efficacy study.high pulmonary vascular pressure associated with scleroderma100192801001076110037454NL-OMON30491Vrije Universiteit Medisch Centrum20
Completed
Not Applicable
The effects of epidermal growth factor receptor inhibition on pulmonary arterial hypertension associated with systemic sclerosisSclerosis-associated Pulmonary Arterial Hypertension (SScPAH)Circulatory SystemPulmonary Arterial HypertensionISRCTN75611179VU University Medical Centre (The Netherlands)20
Suspended
Phase 2
Panitumumab as second line therapy for advanced pancreatic ductal adenocarcinoma with wild-type KRAS geneKRAS wild-type unresectable or metastatic pancreatic ductal adenocarcinomaCancer - PancreaticACTRN12617000540314Dr Daniel Croagh24
Recruiting
Not Applicable
ung Cancer Epidermal Growth Factor (EGFR) Gene Mutation Testing in New Zealandung cancerCancer - Lung - Non small cellLung cancerACTRN12615000998549Auckland UniServices Ltd2,000
Recruiting
Phase 1
EGF ointment trialcolon cancer , rectal cancerJPRN-jRCTs041200113Kiyohara Yoshio34